SEC Form 4 · accession 0000891293-17-000104
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard L Love
Director
Period of report
Sep 28, 2017
Accepted (ET)
Oct 2, 2017 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stock | Sep 28, 2017 | S | 4,000 | $3.19 | D | 84,318 | D | |
| common stock | Sep 28, 2017 | S | 700 | $3.195 | D | 83,618 | D | |
| common stock | Sep 28, 2017 | S | 2,747 | $3.20 | D | 80,871 | D | |
| common stock | Sep 28, 2017 | S | 200 | $3.205 | D | 80,671 | D | |
| common stock | Sep 28, 2017 | S | 100 | $3.2075 | D | 80,571 | D | |
| common stock | Sep 28, 2017 | S | 1,000 | $3.21 | D | 79,571 | D | |
| common stock | Sep 28, 2017 | S | 100 | $3.215 | D | 79,471 | D | |
| common stock | Sep 28, 2017 | S | 600 | $3.22 | D | 78,871 | D | |
| common stock | Sep 28, 2017 | S | 25 | $3.225 | D | 78,846 | D | |
| common stock | Sep 28, 2017 | S | 1,675 | $3.23 | D | 77,171 | D | |
| common stock | Sep 28, 2017 | S | 1,600 | $3.2301 | D | 75,571 | D | |
| common stock | Sep 28, 2017 | S | 200 | $3.235 | D | 75,371 | D | |
| common stock | Sep 28, 2017 | S | 477 | $3.24 | D | 74,894 | D | |
| common stock | Sep 28, 2017 | S | 200 | $3.25 | D | 74,694 | D | |
| common stock | Sep 29, 2017 | S | 976 | $3.20 | D | 73,718 | D |
Table II — derivative securities
No Table II lines on this filing.